Effectiveness of the Quotient® ADHD Assessment in a System of Care

This study is a randomized, controlled trial using a 2-phase data collection. The first
phase is the initial assessment for ADHD and includes all patients eligible to be assessed
for ADHD as determined by their clinician in the course of usual care. The baseline
measurements will be used to compare groups at baseline, and also for longitudinal analyses
of medication management. Patients are randomized at this point. Patients in both treatment
arms who then receive an ADHD diagnosis and who start medication for ADHD will be eligible
for the second phase of the study: three follow-up assessments over six months. Patients who
do not have an ADHD diagnosis will not continue in the study, and will be treated by their
clinician as usual.

Inclusion Criteria:

- All patients within the specified age range who are English speaking and who are
presenting for ADHD assessment are eligible. An additional criterion is consent to be
randomized.

Exclusion Criteria:

- Non English speaking

- Refusal to participate